Tango Therapeutics Inc (TNGX)

Date: O: H: L: C: Vol:

Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	53.81	3.18
	22.59%59.79	48.77	41.86	39.74	44.15
Research and Development	10.93%37.20	33.53	32.10	30.82	32.81
Operating Income/Loss	22.59%-59.79	-48.77	-41.86	14.07	-40.97
Net Interest Income/Expense	71.02%3.72	2.18	1.68	1.10	1.24
Nonoperating Income/Loss	36.52%4.45	3.26	3.06	1.80	2.15
Income/Loss From Continuing Operations Before Tax	21.59%-55.34	-45.51	-38.80	15.87	-38.82
Income Tax Expense/Benefit	0.00	0.00	-0.06	-0.01	0.04
	21.59%-55.34	-45.51	-38.75	15.88	-38.85
Attributable To Parent	21.59%-55.34	-45.51	-38.75	15.88	-38.85
Basic Average Shares	4.39%149.88	143.58	5.40	110.97	110.54
Diluted Average Shares	4.39%149.88	143.58	5.40	117.78	110.54
Basic Earnings Per Share	15.62%-0.37	-0.32	-0.30	0.14	-0.35
Diluted Earnings Per Share	15.62%-0.37	-0.32	-0.30	0.13	-0.35